2023
Solid-Tubulocystic carcinoma: A new variant of intrahepatic cholangiocarcinoma
González I, Luo W, Zhang X. Solid-Tubulocystic carcinoma: A new variant of intrahepatic cholangiocarcinoma. World Journal Of Hepatology 2023, 15: 897-903. PMID: 37547028, PMCID: PMC10401414, DOI: 10.4254/wjh.v15.i7.897.Peer-Reviewed Original ResearchVariant of intrahepatic cholangiocarcinomaIntrahepatic cholangiocarcinomaExpression of inhibinMetastatic hepatic neoplasmsCystic growth patternDiagnostic work-upRecurrent gene fusionsModerate amount of eosinophilic cytoplasmGene fusionsAmount of eosinophilic cytoplasmImmunohistochemical profileClinicopathological featuresEosinophilic cytoplasmBiliary markersTumor cellsMorphologic spectrumHepatic massHepatic neoplasmsWork-upHepatic carcinomaVariantsYoung womenInhibinTumorCholangiocarcinoma
2018
Non-invasive evaluation of a liver mass in a patient post splenectomy
Smolen B, Khoury J, Baruch Y, Saadi T. Non-invasive evaluation of a liver mass in a patient post splenectomy. Scottish Medical Journal 2018, 64: 35-39. PMID: 30380995, DOI: 10.1177/0036933018801449.Peer-Reviewed Case Reports and Technical NotesConceptsRed blood cell scintigraphySmall bowel obstructionLeft upper quadrantNon-invasive evaluationBowel obstructionAbdominal traumaElective splenectomyLiver biopsyUpper quadrantHepatic massRare conditionPost splenectomyInvasive investigationsPeritoneal cavityCorrect diagnosisLiver massAccidental lesionsLiver lesionsSplenic pulpSpillage of cellsSplenosisSplenectomyScintigraphyLesionsNumerous conditionsA practical diagnostic approach to hepatic masses.
Vyas M, Jain D. A practical diagnostic approach to hepatic masses. Indian Journal Of Pathology And Microbiology 2018, 61: 2-17. PMID: 29567877, DOI: 10.4103/ijpm.ijpm_578_17.Peer-Reviewed Original ResearchConceptsDifferential diagnosisHepatic massCorrect diagnosisRight diagnosisBackground liver diseaseUnknown primary siteFocal nodular hyperplasiaHepatic mass lesionsPractical diagnostic approachList of antibodiesNonhepatocellular originProper workupClinical presentationHepatocellular originLiver diseaseHistologic featuresPrimary lesionClinicopathological correlationHepatic adenomaVascular tumorsMass lesionNonepithelial neoplasmsCommon siteNeedle biopsyNodular hyperplasia
2013
Diagnostic Approach to Hepatic Mass Lesions and Role of Immunohistochemistry
Marginean EC, Gown AM, Jain D. Diagnostic Approach to Hepatic Mass Lesions and Role of Immunohistochemistry. Surgical Pathology Clinics 2013, 6: 333-365. PMID: 26838978, DOI: 10.1016/j.path.2013.03.005.Peer-Reviewed Original ResearchFocal nodular hyperplasiaHepatic mass lesionsMass lesionHepatocellular carcinomaHepatic adenomaDifferential diagnosisDiagnostic approachCommon mass lesionsPrimary hepatic neoplasmsRole of immunohistochemistryCommon malignant tumorPractical diagnostic approachYounger patientsHepatic massMacroregenerative nodulesNoncirrhotic liverNodular hyperplasiaCirrhotic liverImmunohistochemical stainsMalignant tumorsHepatic neoplasmsMalignant lesionsClinical practiceDysplastic nodulesLesions
2008
Diagnostic approach to needle biopsies of hepatic mass lesions
Mitchell K, Jain D. Diagnostic approach to needle biopsies of hepatic mass lesions. Diagnostic Histopathology 2008, 14: 598-608. DOI: 10.1016/j.mpdhp.2008.09.004.Peer-Reviewed Original Research
2002
Diagnosis of Hepatocellular Carcinoma
Jain D. Diagnosis of Hepatocellular Carcinoma. Journal Of Clinical Gastroenterology 2002, 35: s101-s108. PMID: 12394213, DOI: 10.1097/00004836-200211002-00006.Peer-Reviewed Original ResearchConceptsFine needle aspiration cytologyNeedle core biopsyHepatic massHepatic nodulesLarge hepatic massMetastatic hepatic massesHigh-risk patientsNeedle aspiration cytologyDiagnosis of HCCMost clinical settingsPositive predictive valueDifferentiated HCCRisk patientsSmall hepatic nodulesPathologic evaluationPathologic diagnosisCore biopsyDiagnostic difficultiesHistopathologic diagnosisImmunohistochemical stainsHepatocellular carcinomaInstitutional experienceAspiration cytologyHepatic lesionsPredictive value
2000
Solitary fibrous tumor of the liver: imaging findings.
Fuksbrumer M, Klimstra D, Panicek D. Solitary fibrous tumor of the liver: imaging findings. American Journal Of Roentgenology 2000, 175: 1683-7. PMID: 11090404, DOI: 10.2214/ajr.175.6.1751683.Peer-Reviewed Original ResearchEfficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: Results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging
Federle M, Chezmar J, Rubin D, Weinreb J, Freeny P, Schmiedl U, Brown J, Borrello J, Lee J, Semelka R, Mattrey R, Dachman A, Saini S, Harms S, Mitchell D, Anderson M, Halford H, Bennett W, Young S, Rifkin M, Gay S, Ballerini R, Sherwin P, Robison R. Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: Results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging. Journal Of Magnetic Resonance Imaging 2000, 12: 689-701. PMID: 11050638, DOI: 10.1002/1522-2586(200011)12:5<689::aid-jmri5>3.0.co;2-z.Peer-Reviewed Original ResearchConceptsUnenhanced magnetic resonance imagingMagnetic resonance imagingMangafodipir trisodium injectionFinal diagnosisMulticenter phase III clinical trialContrast-enhanced computed tomography examinationPhase III clinical trialsContrast-enhanced magnetic resonance imagingInjection of MnDPDPPatient's final diagnosisHepatic magnetic resonance imagingComputed tomography examinationEnhanced magnetic resonance imagingFocal liver diseaseAdditional diagnostic informationFocal liver lesionsLiver diseaseEarly imagingMRI evaluationHepatic massClinical trialsTomography examinationIntravenous administrationPatient managementRadiologic diagnosisBiliary copper excretion capacity in intact animals: Correlation between ATP7B function, hepatic mass, and biliary copper excretion
Schilsky M, Irani A, Gorla G, Volenberg I, Gupta S. Biliary copper excretion capacity in intact animals: Correlation between ATP7B function, hepatic mass, and biliary copper excretion. Journal Of Biochemical And Molecular Toxicology 2000, 14: 210-214. PMID: 10789499, DOI: 10.1002/(sici)1099-0461(2000)14:4<210::aid-jbt5>3.0.co;2-g.Peer-Reviewed Original ResearchConceptsBiliary copper excretionCopper excretionLong-Evans AgoutiHepatic massIntact animalsLEA ratsLEC ratsExcretion capacityMinute study periodTwo-thirds partial hepatectomyLong-Evans Cinnamon ratsBile collectionPathophysiological mechanismsNovel therapiesHepatocyte massExcretionRatsPartial hepatectomyTransient increaseStudy periodATP7B functionOne-third
1998
MR-Guided Needle Aspiration Biopsies of Hepatic Masses Using a Closed Bore Magnet
Rofsky N, Yang B, Schlossberg P, Goldenberg A, Teperman L, Weinreb J. MR-Guided Needle Aspiration Biopsies of Hepatic Masses Using a Closed Bore Magnet. Journal Of Computer Assisted Tomography 1998, 22: 633-637. PMID: 9676459, DOI: 10.1097/00004728-199807000-00024.Peer-Reviewed Original ResearchConceptsNeedle aspiration biopsyHepatic massAspiration biopsyMR guidanceEfficacy of MRMetastatic carcinomaBiopsy specimensTarget lesionsNoncontrast CTHepatocellular carcinomaHepatic lesionsFocal lesionsBiopsyNecrotic materialBenign hepatocytesPatientsLesionsSmall lesionsMR-compatible needlesNondiagnostic materialPrevious CT
1995
Gadoteridol-enhanced MR imaging of malignant hepatic tumors: effects of triple versus standard doses on lesion-liver contrast.
Petersein J, Saini S, Mitchell D, Davis P, Johnson C, Kuhlman J, Parisky Y, Runge V, Weinreb J, Bernardino M. Gadoteridol-enhanced MR imaging of malignant hepatic tumors: effects of triple versus standard doses on lesion-liver contrast. American Journal Of Roentgenology 1995, 165: 1157-61. PMID: 7572495, DOI: 10.2214/ajr.165.5.7572495.Peer-Reviewed Original ResearchConceptsLesion-liver CNRLesion-liver contrastStandard doseHepatic lesionsMR imagingMalignant hepatic tumorsMalignant liver lesionsMalignant hepatic massesAdministration of gadoteridolMalignant hepatic lesionsT1-weighted spin-echo imagingLiver MR imagingStandard dosesHepatic massHepatic tumorsTriple doseHigh doseMalignant lesionsLiver lesionsLesionsLiver SNRDoseTime pointsGradient-echo imagingLiver signal
1987
CT Features of Hemorrhagic Malignant Liver Tumors
Siskind B, Malat J, Hammers L, Rigsby C, Taylor C, Radin D, Rosenfield A. CT Features of Hemorrhagic Malignant Liver Tumors. Journal Of Computer Assisted Tomography 1987, 11: 766-770. PMID: 2821089, DOI: 10.1097/00004728-198709000-00004.Peer-Reviewed Original ResearchConceptsMetastatic colon carcinomaPrimary hepatic malignancySetting of anticoagulationMalignant liver tumorsPerihepatic fluidHemorrhagic complicationsHepatic metastasesCT featuresHepatic malignanciesHepatic massNoncontrast scansPeritoneal fluidSubcapsular fluidRadiographic signsHepatocellular carcinomaLiver tumorsPatientsColon carcinomaHemorrhageLiver borderComplicationsCarcinomaTumorsHematocrit effectLiver
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply